Enhanced solubility and dissolution rate of lamotrigine by inclusion complexation and solid dispersion technique

Journal of Pharmacy and Pharmacology

Volumn 60, Issue 9, 2008, Pages 1121-1129

  Shinde, Vikram R ^a   Shelake, Makarand R ^b   Shetty, Sandeep S ^a   Chavan Patil, Amit B ^a   Pore, Yogesh V ^a   Late, Sameer G ^c  

^a Government College of Pharmacy   (India)

^b BHARATI VIDYAPEETH DEEMED UNIVERSITY   (India)

^c MERCER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LAMOTRIGINE; MACROGOL 6000; POVIDONE;

ARTICLE; DIFFERENTIAL SCANNING CALORIMETRY; DRUG SOLUBILITY; DRUG STABILITY; INFRARED SPECTROSCOPY; SOLID STATE; X RAY DIFFRACTION;

ANTICONVULSANTS; BETA-CYCLODEXTRINS; CALORIMETRY, DIFFERENTIAL SCANNING; CRYSTALLIZATION; DRUG CARRIERS; POLYETHYLENE GLYCOLS; POVIDONE; SOLUBILITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; TRIAZINES; X-RAY DIFFRACTION;

EID: 49849086012     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/jpp.60.9.0002     Document Type: Article

References (53)

1. Archontaki, H. A., Vertzoni, M. V., Athanassiou-Malaki, M. H. (2002) Study on the inclusion complexes of bromazepam with β-and β-hydroxypropyl-cyclodextrins. J. Pharm. Biomed. Anal. 28(3-4): 761-769
2. Bruce, J. A. (2000) Intestinal permeation enhancers - mini-review. J. Pharm. Sci. 89: 429-441
3. Brun, H., Paul, M., Razzouq, N., Binhas, M., Gibaud, S., Astier, A. (2006) Cyclodextrin inclusion complexes of the central analgesic drug nefopam. Drug Dev. Ind. Pharm. 32: 1123-1134
4. Chiou, W. L., Riegelman, S. (1971) Pharmaceutical applications of solid dispersion systems. J. Pharm. Sci. 60: 1281-1302
5. Chong, E., Dupuis, L. L. (2002) Therapeutic drug monitoring of lamotrigine. Ann. Pharmacother. 36: 917-920
6. Christian, L., Dressman, J. (2000) Improving drug solubility for oral delivery using solid dispersions. Eur. J. Pharm. Biopharm. 50: 47-60
7. Cirri, M., Mura, P., Rabasco, A. M., Gines, J. M., Moyano, J. R., Gonzalez-Rodriguez, M. L. (2004) Characterization of ibuproxam binary and ternary dispersions with hydrophilic carriers. Drug Dev. Ind. Pharm. 30: 65-74
8. Corrigan, O. I., Holohan, E. M., Reilly, M. R. (1985) Physicochemical properties of indomethacin and related compound co-spray dried with polyvinyl pyrrolidone. Drug Dev. Ind. Pharm. 11: 677-695
9. Damian, F., Blaton, N., Naesens, L., Balzarini, J., Kinget, R., Augustijns, P., Van den Mooter, G. (2000) Physicochemical characterization of solid dispersions of the antiviral agent UC-781 with polyethylene glycol 6000 and Gelucire 44/14. Eur. J. Pharm. Sci. 10: 311-322
10. Echezarreta-Lopez, M., Torres-Labandeira, J. J., Castineiras-Seijo, L., Santana-Penin, L., Vila-Jato, J. L. (2000) Complexation of the interferon inducer, bropirimine, with hydroxypropyl-b-cyclodextrin. Eur. J. Pharm. Sci. 9: 381-386
11. Fernandes, C. M., Vieira, M. T., Viega, F. J. (2002) Physicochemical characterization and in vitro dissolution behaviour of nicardipine-cyclodextrins inclusion compounds. Eur. J. Pharm. Sci. 15: 79-88
12. Ford, J. L. (1986) The current status of solid dispersions. Pharm. Acta Helv. 61: 69-88
13. Franco, M., Trapani, G., Latrofa, A., Tullio, C., Provenzano, M. R., Serra, M., Muggironi, M., Biggio, G., Liso, G. (2001) Dissolution properties and anticonvulsant activity of phenytoin-polyethylene glycol 6000 and -polyvinylpyrrolidone K-30 solid dispersions. Int. J. Pharm. 225: 63-73
14. Geneidi, A. S., Ali, A. A., Salama, R. B. (1978) Solid dispersions of nitrofurantoin, ethotoin and coumarin with polyethylene glycol 6000 and other coprecipitates with povidone 25000. J. Pharm. Sci. 67: 114-116
15. Gian, C., Paolo, C., Simone, L. (2002) Skin permeation study of dehydroepiandrosterone (DHEA) compared with its α-cyclodextrin complex form. J. Pharm. Sci. 91: 2399-2405
16. Giordano, F., Novák, C., Moyano, J. R. (2001) Thermal analysis of cyclodextrins and their inclusion compounds. Thermochim. Acta 380:123-151
17. Gupta, P., Kakumanu, V. K., Bansal, A. K. (2004) Stability and solubility of celecoxib-PVP amorphous dispersions: a molecular perspective. Pharm. Res. 21: 1762-1769
18. Hancock, B. C., Zografi, G. (1997) Characteristics and significance of the amorphous state in pharmaceutical systems. J. Pharm. Sci. 86: 1-12
19. Henck, J. O., Griesser, U. J., Burger, A. (1997) Polymorphie von Arzneistoffen. Eine wirtschaftliche Herausforderung? Pharm. Ind. 59:165-169
20. Higuchi, T., Connors, K. A. (1965) Phase-solubility techniques. Adv. Anal. Chem. Instr. 4: 117-212
21. Horter, D., Dressman, J. B. (1997) Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract. Adv. Drug Deliv. Rev. 25:3-14
22. Hurley, S. C. (2002) Lamotrigine update and its use in mood disorders. Ann. Pharmacother. 36: 860-873
23. Internet Drug Index (2007) Available at www. rxlist. com/cgi/generic/ lamotrigine.htm. Accessed April 10, 2007
24. Kim, E. J., Chun, M. K., Jang, J. S. (2006) Preparation of a solid dispersion of felodipine using a solvent wetting method. Eur. J. Pharm. Biopharm. 64: 200-205
25. Loftsson, T., Bodor, N. (1995) The effect of cyclodextrins on percutaneous transport of drugs. In: Smith, E. W., Maibach, H. I. (eds) Percutaneous penetration enhancers. CRC Press, Boca Raton, pp 335-342
26. Loftsson, T., Brewster, M. E. (1996) Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization. J. Pharm. Sci. 85: 1017-1025
27. Longxiao, L., Suyan, Z. (2006) Preparation and characterization of inclusion complexes of prazosin hydrochloride with β-cyclodextrin and hydroxypropyl-β-cyclodextrin. J. Pharm. Biomed. Anal. 40: 122-127
28. Mar, M., Thorsteinn, L., Gisli, M. (1999) Cyclodextrins as permeation enhancers: some theoretical evaluation and in-vitro testing. J. Control. Release 59: 107-118
29. Masson, M., Loftsson, T., Masson, G., Stefanson, E. (1999) Cyclodextrins as permeation enhancers: some theoretical evaluations and in vitro testing. J. Control. Release 59: 107-118
30. Mooter, G., Augustijns, P., Blaton, N., Kinget, R. (1998) Physicochemical characterization of solid dispersions of temazepam with polyethylene glycol 6000 and PVP K30. Int. J. Pharm. 164: 67-80
31. Mukne, A. P., Nagarsenker, M. S. (2004) Triamterene-β-cyclodextrin systems: preparation, characterization and in vivo evaluation. AAPS Pharm. Sci. Tech. 5(1); Article 19: 1-9
32. Mura, P., Faucci, M. T., Parrini, P. L., Furlanetto, S., Pinzauti, S. (1999) Influence of the preparation method on the physicochemical properties of ketoprofen-cyclodextrin binary systems. Int. J. Pharm. 179: 117-128
33. Perucca, E. (2000) Is there a role for therapeutic drug monitoring of new anticonvulsants? Clin. Pharmacokinet. 38: 191-204
34. Ruan, L. P., Yu, B. Y., Fu, G. M., Zhu, D. (2005) Improving the solubility of ampelopsin by solid dispersions and inclusion complexes. J. Pharm. Biomed. Anal. 38: 457-464
35. Ryan, J A. (1986) Compressed pellet x-ray diffraction monitoring for optimisation of crystallinity in lyophilised solids: imipenem: cilastatin sodium case. J. Pharm. Sci. 75: 805-807
36. Sammour, O. A., Hammad, M. A., Megrab, N. A., Zidan, A. S. (2006) Formulation and optimization of mouth dissolve tablets containing rofecoxib solid dispersion. AAPS Pharm. Sci. Tech. 7 (2), Article 55: E1-E9
37. Save, T., Venkitachalam, P. (1992) Studies on solid dispersions of nifedipine. Drug Dev. Ind. Pharm. 18: 1663-1679
38. Schott, H., Kwan, L. C., Feldman, S. (1982) The role of surfactant in the release of very slightly soluble drugs from tablets. J. Pharm. Sci. 71: 1038-1045
39. Sekikawa, H., Nakano, M., Arita, T. (1978) Inhibitory effect of poly-vinylpyrrolidone on the crystallization of drugs. Chem. Pharm. Bull. 26: 118-126
40. Serajuddin, A. T. M. (1999) Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent break-throughs. J. Pharm. Sci. 88, 1058-1066
41. Sethia, S., Squillante, E. (2004) Solid dispersion of carbamazepine in PVP K30 by conventional solvent evaporation and supercritical methods. Int. J. Pharm. 272: 1-10
42. Sweetman, S. C. (ed) (2002) Martindale: the complete drug reference, 33rd edn. Pharmaceutical Press, London. pp 351-352
43. Szetli, J. (1994) Medicinal applications of cyclodextrins. Med. Res. Rev. 14: 353-386
44. Tantishaiyakul, V., Kaewnopparat, N., Ingkatawornwong, S. (1999) Properties of solid dispersions of piroxicam in polyvinylpyrrolidone. Int. J. Pharm. 181: 143-151
45. Trapani, G., Franco, M., Latrofa, A., Pantaleo, M. R., Provenzano, M. R., Sanna, E., Maciocco, E., Liso, G. (1999) Physicochemical characterization and in vivo properties of Zolpidem in solid dispersions with polyethylene glycol 4000 and 6000. Int. J. Pharm. 184: 121-130
46. Trapani, G., Latrofa, A., Franco, M. (2000) Complexation of zolpidem with 2-hydroxypropyl-β-, methyl-β-, and 2-hydroxypropyl-γ- cyclodextrin: effect on aqueous solubility, dissolution rate and ataxic activity in rat. J. Pharm. Sci. 89: 1443-1451
47. Uekama, K., Hirayama, F. (1996) Improvement of drug properties by cyclodextrin, In: Wermuth, C. G. (ed) The practice of medicinal chemistry, Academic Press, London, pp 793-825
48. US FDA. www.accessdata.fda.gov/scripts/cder/dissolution/ dsp_SearchResults_Dissolutions.cfm?PrintAll= l. Accessed November 30, 2006
49. Vandelli, M. A. Salvioli, G., Mucci, A., Panini, R., Malmusi, L. (1995) 2-Hydroxypropyl-β-cyclodextrin complexation with ursodeoxycholic acid. Int. J. Pharm. 118: 77-83
50. Veiga, F., Teixeria-Dias, J. J. C., Kedzeierewicz, F., Sousa, A., Maincent, P. (1996) Inclusion complexation of tolbutamide with β-cyclodextrin and hydroxypropyl-β-cyclodextrin. Int. J. Pharm. 129:63-71
51. Veiga, M. D., Diaz, P. J., Ahsan, F. (1998) Interactions of griseofulvin with cyclodextrins in solid binary systems. J. Pharm. Sci. 87: 891-900
52. Verheyen, S., Blaton, N., Kinget, R., Van den Mooter, G. (2002) Mechanism of increased dissolution of diazepam and temazepam from polyethylene glycol 6000 solid dispersions. Int. J. Pharm. 249:45-58
53. Yagi, N., Terashima, Y., Kenmotsu, H., Sekikawa, H., Takada, M. (1996) Dissolution behaviour of probucol from solid dispersion systems of probucol-polyvinylpyrrolidone. Chem. Pharm. Bull. 44: 241-244